Wall Street equity research analysts tracking Encompass Health Corporation maintain an average 12-month consensus price target reflecting positive sentiment regarding its dominant post-acute care positioning. Forward-looking projections span from conservative baseline estimates up to optimistic bull targets, driven by steady occupancy rates, strategic hospital expansions through joint ventures, and robust demographic trends among aging populations requiring specialized inpatient rehabilitation services.